North Texas Infectious Disease Consultants

Dallas, Texas 75246

0 studies enrolling now · 11 studies all time

What they study most

Cytomegalovirus Retinitis, HIV, HIV Infection, HIV Infections, HIV-1 Infection, HIV-1-infection, MPOX

Studies at this site

• Study of Tecovirimat for Human Mpox Virus — Stopped early
• TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals — Completed
• Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection — Completed
• Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants — Completed
• Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1 — Completed
• Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV — Completed
• Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir — Completed
• Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive — Stopped early
• Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1 — Completed
• A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients — Completed
• Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection — Status unconfirmed